Skip to content
Beacon

MSOXAdvisorShares MSOS Daily Leveraged ETF

Take a bet3y track recordRanked #182 of 949 in this goal

Seeks daily investment results that correspond to approximately 200% of the daily total return of the US Cannabis ETF.

By AdvisorShares · Launched 2022

Annual Cost

0.97%

#5,031 of 5,861 · expensive

Fund Size

$69M

#3,326 of 5,861 · mid-size

Return (1Y)Goal

-71.0%

Track Record

3 years

#2,693 of 5,861 · seasoned

Performance

Total-return NAV · USD
Growth of $10,000
$3,133-68.7%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Leveraged

What it actually holds

By weight

Concentration

synthetic exposure — holdings shown are derivatives collateral, not the fund's positions

CLEAR STREET LLC
4.6%
BLACKROCK TREASURY TRUST
1.7%
AdvisorShares Trust
0.0%
COWEN INC.
-1.7%
COWEN INC.
-10.1%

Asset allocation

Cash
93.6%
Bonds
3.3%
Other
3.2%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
189.4%High

Year-on-year price swings

Max drawdown
-99.9%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.01Below average
Sortino (3Y)
0.01Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks daily investment results that correspond to approximately 200% of the daily total return of the US Cannabis ETF.
Strategy
Actively managed ETF aiming for 2x daily returns of the US Cannabis ETF through swap agreements. Concentrates at least 25% in pharmaceuticals, biotechnology & life sciences within the health care sector, focusing on mid- and small-cap companies in the U.S. cannabis market.
Inception date
August 23, 2022
Fund family
AdvisorShares

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged
Warning

Your return drifts the longer you hold

Leverage amplifies the index's daily move, by 2x or 3x. The fund resets every day, so over weeks and months your real return drifts from that multiple. It can run ahead in a smooth climb and bleed in a choppy one. Hold one for months and you own a different bet than the label suggests.

Sources: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at MSOX. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04